x
Loading...
Sysmex Europe GmbH
Bornbarch 1
22848 Norderstedt
Phone: +49 (40) 527 26 0
Fax: +49 (40) 527 26 100
info@sysmex-europe.com
Want to leave us a message or have us call you back? Use our Email Contact-Form!
x
Patient Portal
Sysmex is active in a broad spectrum of healthcare areas. In addtion
to information for healthcare professionals we also provide
applied information for privat individuals seeking assistance in our
areas of expertise.
At the moment we provide guidance and background info on
breast cancer. We welcome you to visit http://www.breast-cancer-diagnosis.co.uk/
Press releases
Here´s your quick access to our latest press releases.
Sysmex Launches New Products in Its System for the Testing of Cancer Lymph Node Metastasis Using the OSNA™ Method: Gene Amplification Detector RD-200 and LYNOAMP™ CK19
Sysmex Group Formulates New Long-Term Management Goals
Sysmex Announces “Sysmex Eco-Vision 2025”
Sysmex to Establish Bio-Diagnostic Reagent Center
Sysmex Employee to Receive the “Medal with Purple Ribbon,” a Spring 2018 Medal of Honor
Sysmex to Launch JICA Project in the Republic of Ghana: "Collaboration Program for Disseminating Automated Urinalysis Diagnosis Technology”
Sysmex Europe GmbH to Transfer Management of All European Installations of The DigniCap Scalp Cooling System Back to Dignitana AB
Sysmex Launches Caresphere™, a New Network Solution
Advanced Medical Care Approval Received for Multiplex Gene Panel Testing to Advancing Personalized Medicine
Sysmex Formulates New Corporate Message:“Lighting the way with diagnostics”
Japan’s first-ever industry-academia alliance to realize the development of innovative medicine in Japan
OncoBEAM™ RAS CRC liquid biopsy test now reimbursed in Germany by BARMER
Sysmex to Be Special Sponsor of the Kobe Marathon 2018
Sysmex Celebrates Its 50th Anniversary of Establishment
A fondo: Comparación de los resultados obtenidos en los análisis de biopsias líquidas OncoBEAM RAS CRC e Idylla ctKRAS para la detección de la mutación KRAS presentados en la reunión GI de la ASCO en 2018
In depth: Performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS liquid biopsy testing for KRAS mutation detection presented at ASCO GI 2018
In depth: Performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS liquid biopsy testing for KRAS mutation detection presented at ASCO GI 2018
Comparación de los resultados obtenidos con OncoBEAM™ RAS CRC y el test Idylla ct KRAS presentados en la reunión ASCO GI 2018
Liquid Biopsy performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS testing presented at ASCO GI 2018 meeting
Sysmex invests in Megakaryon Corporation to contribute to the practical realization of platelet preparations derived from iPS cells
Sysmex to Commence OncoBEAM™ Lab Assay Services (for Research) in Japan, as well as in Germany and the United States, to Analyze Genetic Mutations Related to Circulating Tumor DNA
Expert Taskforce Recommendation of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients
